Arcturus Therapeutics Holdings' loss under GAAP for 9 months of 2020 amounted to $41.044 million, an increase of 2.7 times compared to $15.002 million in the previous year. Revenue decreased 2.6 times to $7.301 million, against $17.821 million a year earlier.